
Prescription required
Reviewed by:
Prescription required
Doxycycline is a tetracycline-class antibiotic that, when formulated as Oracea, functions uniquely as a synthetic, sub-antimicrobial systemic anti-inflammatory agent. It is indicated exclusively for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients, and is not effective for bacterial infections or non-inflammatory manifestations of rosacea. At its 40 mg modified-release dose, it operates below the minimum inhibitory concentration required to inhibit bacterial growth, instead suppressing matrix metalloproteinases, pro-inflammatory cytokines, and neutrophil migration. This design separates anti-inflammatory efficacy from antibiotic activity, minimizing the risk of developing systemic bacterial resistance.
Ready to Fill
Doxycycline
Oracea
Tetracycline-class antibiotic; anti-inflammatory agent (low-dose modified-release formulation for rosacea)
No
Oral modified-release capsules (40 mg)
Basics
Doxycycline is a tetracycline-class antibiotic. However, when formulated as Oracea, it functions uniquely as a synthetic, sub-antimicrobial systemic anti-inflammatory agent.
Clinically, Oracea is indicated exclusively for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients, to reduce localized facial redness and inflammatory breakouts. Crucially, Oracea lacks meaningful antibacterial activity and is not indicated for the treatment of bacterial infections, nor is it effective for the non-inflammatory ocular or phymatous (tissue-thickening) manifestations of rosacea. Its design separates anti-inflammatory efficacy from antibiotic activity, minimizing the risk of developing systemic bacterial resistance.
Indications
Oracea is indicated exclusively for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients. It is not indicated for the treatment of bacterial infections, and is not effective for the non-inflammatory ocular or phymatous manifestations of rosacea.
Mechanism
Pharmacodynamics and the Sub-Antimicrobial Threshold
In the pathophysiology of rosacea, localized cutaneous inflammation is driven by overproduction of tissue-destructive enzymes and activation of pro-inflammatory pathways. Traditional high-dose doxycycline (100–200 mg daily) treats acne or infections by exceeding the Minimum Inhibitory Concentration (MIC) required to inhibit bacterial growth.
Oracea functions entirely below this antibiotic threshold. At a 40 mg dose, it operates as a selective matrix metalloproteinase (MMP) inhibitor and immunomodulator:
Pharmacokinetics
Dosage
Standard Clinical Dosing Protocols
Strict Administration Guidelines
The Esophageal Ulceration Prevention Mandate
Every Oracea capsule must be swallowed with a full 8-ounce glass of plain water while standing or sitting completely upright. The patient must remain completely upright (do not lie down) for at least 30 minutes after administration. If a tetracycline capsule becomes lodged in the esophagus, its local chemical profile can cause severe mucosal erosion, leading to acute esophageal ulcerations, severe dysphagia, and hematemesis.
Component Matrix Handling: Capsules must be swallowed completely whole. Do not open, chew, or crush the capsule, as destroying the dual-bead setup compromises the delayed-release matrix, causing immediate drug dumping in the stomach and increasing gastric distress.
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Absolute Contraindications
Oracea is strictly contraindicated in:
Severe Drug-Induced Photosensitivity
Permanent Dental Discoloration and Bone Growth Retardation
Pseudotumor Cerebri (Benign Intracranial Hypertension)
Severe Gastric and Cutaneous Hypersensitivity Reactions
Common Adverse Reactions
The most frequent side effects documented across clinical trials are typically mild and self-limiting:
Interactions
Contraindications
Pregnancy and Lactation
Geriatric Care
Clinical evaluations did not demonstrate distinct differences in safety profiles or therapeutic responses between older adults aged 65 and over and younger individuals. Dosing remains fixed at 40 mg once daily, but requires typical vigilance regarding baseline esophageal motility and concurrent multi-medication checks.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill